Pyxis Oncology (PYXS) Total Liabilities (2020 - 2025)

Pyxis Oncology (PYXS) has 6 years of Total Liabilities data on file, last reported at $38.1 million in Q4 2025.

• Total Liabilities for Q4 2025 came in at $38.1 million, up 4.62% year-over-year; the trailing twelve-month figure through Dec 2025 was $38.1 million (up 4.62% YoY), and the FY2025 annual result was $38.1 million, up 4.62% from the prior year.
• Total Liabilities improved to $38.1 million in Q4 2025 per PYXS's latest filing, from $36.8 million in the prior quarter.
• Over five years, Total Liabilities peaked at $57.6 million in Q2 2021 and troughed at $16.9 million in Q3 2021.
• A 5-year average of $36.6 million and a median of $36.2 million in 2024 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2021 and 2022: Total Liabilities soared 385.42% in 2021, then slumped 61.64% in 2022.
• A 5-year view of Total Liabilities shows it stood at $18.7 million in 2021, then surged by 170.23% to $50.6 million in 2022, then decreased by 5.01% to $48.0 million in 2023, then slipped by 24.14% to $36.4 million in 2024, then increased by 4.62% to $38.1 million in 2025.
• Business Quant data shows PYXS's Total Liabilities at $38.1 million in Q4 2025, $36.8 million in Q3 2025, and $35.6 million in Q2 2025.